Pain Relief 4% Lidocaine Dry Patch
NDC Package 71309-911-15
Package Information
Pain Relief 4% Lidocaine Dry Patch is adults and children over 12 years:clean and dry affected arearemove backing from patch by firmly grasping both ends and gently pulling until backing separates in middlecarefully remove smaller portion of backing from patch and apply exposed portion of patch to affected areaonce exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected areause 1 patch for up to 12 hourschildren 12 years or younger: ask a doctor. Marketed by Safrel Pharmaceuticals, Llc, this product is identified by NDC 71309-911 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1737778 - lidocaine 4 % Medicated Patch
- RxCUI: 1737778 - lidocaine 0.04 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71309 - Safrel Pharmaceuticals, Llc
- 71309-911 - Pain Relief 4% Lidocaine Dry Patch
- 71309-911-15 - 15 POUCH in 1 BOX / 1 PATCH in 1 POUCH
- 71309-911 - Pain Relief 4% Lidocaine Dry Patch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71309-911-15 identifies a specific commercial package of 15 pouch in 1 box / 1 patch in 1 pouch of Pain Relief 4% Lidocaine Dry Patch, labeled by Safrel Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Safrel Pharmaceuticals, Llc on March 15, 2022. The current certification is valid through December 31, 2023.
How is this Safrel Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71309091115. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.